Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway

Tumor Biology

Volumn 36, Issue 11, 2015, Pages 8661-8670

  Sui, Yanxia ^a   Zheng, Xiaoqiang ^a   Zhao, Dongli ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cell apoptosis; HCC; PI3K AKT signaling; Rab31

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN RAB31; RAS PROTEIN; UNCLASSIFIED DRUG; RAB PROTEIN; RAB31 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ADULT; BIOSYNTHESIS; CELL PROLIFERATION; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADULT; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RAB GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84949098542     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3626-5     Document Type: Article

References (22)

1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.
2. Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, Schwartz M, Han G, Izzo F, Chen M, Blanc JF, Johnson P, Kudo M, Roberts LR, Sherman M: The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 2015.
3. Feo F, Pascale RM. Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? Ann Transl Med. 2015;3:4.
4. Kitagishi Y, Matsuda S. Rufy, rab and rap family proteins involved in a regulation of cell polarity and membrane trafficking. Int J Mol Sci. 2013;14:6487–98.
5. Chua CE, Tang BL: Role of rab gtpases and their interacting proteins in mediating metabolic signalling and regulation. Cell Mol Life Sci 2015.
6. Cheng KW, Lahad JP, Gray JW, Mills GB. Emerging role of rab gtpases in cancer and human disease. Cancer Res. 2005;65:2516–9.
7. Chua CE, Tang BL. The role of the small gtpase rab31 in cancer. J Cell Mol Med. 2015;19:1–10.
8. Jin C, Rajabi H, Pitroda S, Li A, Kharbanda A, Weichselbaum R, et al. Cooperative interaction between the muc1-c oncoprotein and the rab31 gtpase in estrogen receptor-positive breast cancer cells. PLoS One. 2012;7:e39432.
9. Grismayer B, Solch S, Seubert B, Kirchner T, Schafer S, Baretton G, et al. Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells. Mol Cancer. 2012;11:62.
10. Kotzsch M, Dorn J, Doetzer K, Schmalfeldt B, Krol J, Baretton G, et al. Mrna expression levels of the biological factors upar, upar-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer. Biol Chem. 2011;392:1047–51.
11. Serao NV, Delfino KR, Southey BR, Beever JE, Rodriguez-Zas SL. Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med Genom. 2011;4:49.
12. Kunkle BW, Yoo C, Roy D. Reverse engineering of modified genes by Bayesian network analysis defines molecular determinants critical to the development of glioblastoma. PLoS One. 2013;8:e64140.
13. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
14. Agola JO, Jim PA, Ward HH, Basuray S, Wandinger-Ness A. Rab gtpases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet. 2011;80:305–18.
15. Stein MP, Dong J, Wandinger-Ness A. Rab proteins and endocytic trafficking: potential targets for therapeutic intervention. Adv Drug Deliv Rev. 2003;55:1421–37.
16. Li Y, Jia Q, Zhang Q, Wan Y. Rab25 upregulation correlates with the proliferation, migration, and invasion of renal cell carcinoma. Biochem Biophys Res Commun. 2015;458:745–50.
17. Amornphimoltham P, Rechache K, Thompson J, Masedunskas A, Leelahavanichkul K, Patel V, et al. Rab25 regulates invasion and metastasis in head and neck cancer. Clin Cancer Res. 2013;19:1375–88.
18. Fan Y, Wang L, Han X, Liu X, Ma H. Rab25 is responsible for phosphoinositide 3-kinase/aktmediated cisplatin resistance in human epithelial ovarian cancer cells. Mol Med Rep. 2015;11:2173–8.
19. Bie Y, Zhang Z. Rab8a a new biomarker for endometrial cancer? World J Surg Oncol. 2014;12:371.
20. Thomas JD, Zhang YJ, Wei YH, Cho JH, Morris LE, Wang HY, et al. Rab1a is an mtorc1 activator and a colorectal oncogene. Cancer Cell. 2014;26:754–69.
21. Wang Q, Ni Q, Wang X, Zhu H, Wang Z, Huang J. High expression of rab27a and tp53 in pancreatic cancer predicts poor survival. Med Oncol. 2015;32:372.
22. Tsai CH, Cheng HC, Wang YS, Lin P, Jen J, Kuo IY, et al. Small gtpase rab37 targets tissue inhibitor of metalloproteinase 1 for exocytosis and thus suppresses tumour metastasis. Nat Commun. 2014;5:4804.